Antibody against Epstein-Barr virus DNA polymerase activity in sera of patients with nasopharyngeal carcinoma

• Published in: Journal of medical virology Vol. 28; no. 2; p. 101
• Main Authors: Liu, M Y, Chou, W H, Nutter, L, Hsu, M M, Chen, J Y, Yang, C S
• Format: Journal Article
• Language: English
• Published: United States 01.06.1989
• Subjects: Antibodies, Viral - biosynthesis; Antibodies, Viral - radiation effects; Biomarkers, Tumor - immunology; Carcinoma - diagnosis; Carcinoma - immunology; Carcinoma - radiotherapy; DNA-Directed DNA Polymerase - immunology; DNA-Directed DNA Polymerase - metabolism; Follow-Up Studies; Herpesvirus 4, Human - enzymology; Herpesvirus 4, Human - immunology; Humans; Nasopharyngeal Neoplasms - diagnosis; Nasopharyngeal Neoplasms - immunology; Nasopharyngeal Neoplasms - radiotherapy; Prognosis; Random Allocation; Tumor Cells, Cultured
• ISSN: 0146-6615
• DOI: 10.1002/jmv.1890280209

A salt-dependent DNA polymerase activity was demonstrated in the culture of an EBV-producing, lymphoblastoid cell line (NPC-204 cells) treated with 5-iodo-2'-deoxyuridine (IUdR). There was a high frequency of levels of antibody to this enzyme in sera of patients with nasopharyngeal carcinoma (NPC). In contrast, sera from healthy subjects had little or no neutralizing activity. The high antibody level appeared as early as stage 1 of the disease in many NPC patients. The levels of the antibody increased with the progression of the disease and declined in treated patients. The results strongly suggest that tests measuring serum antibody against EBV DNA polymerase activity can be used for early diagnosis and prognosis of NPC.